Literature DB >> 9474476

Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors.

O Cars1.   

Abstract

Only a few years after the introduction of penicillin, resistant staphylococci were isolated in hospitals. This situation has led to the development of semisynthetic penicillins. Today, multiresistant Gram-positive bacteria have become an increasing problem in both hospitals and the community, frequently leaving the glycopeptides as the only therapeutic option. Notable problem pathogens are methicillin-resistant Staphylococcus aureus, coagulase-negative staphylococci and glycopeptide-resistant enterococci in the nosocomial environment, and penicillin-resistant Streptococcus pneumoniae in the community. In the hospital setting, as well as in the community and in animal husbandry, crowding and poor hygiene can facilitate the spread of resistant bacteria selected by antibiotic usage. However, the precise epidemiology and frequency of each drug-resistant pathogen depends on geographical location, the patient group involved and previous antibiotic use. Active measures need to be taken to reduce the spread of these pathogens and thus preserve the efficacy of available antibiotics.

Entities:  

Mesh:

Year:  1997        PMID: 9474476     DOI: 10.2165/00003495-199700546-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  37 in total

1.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.

Authors:  V A Arason; K G Kristinsson; J A Sigurdsson; G Stefánsdóttir; S Mölstad; S Gudmundsson
Journal:  BMJ       Date:  1996-08-17

2.  Multiply antibiotic-resistant Staphylococcus epidermidis in patients, staff and environment--a one-week survey in a bone marrow transplant unit.

Authors:  G Hedin; A Hambraeus
Journal:  J Hosp Infect       Date:  1991-02       Impact factor: 3.926

3.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

4.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

5.  Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study.

Authors:  J M Nava; F Bella; J Garau; J Lite; M A Morera; C Martí; D Fontanals; B Font; V Pineda; S Uriz
Journal:  Clin Infect Dis       Date:  1994-11       Impact factor: 9.079

6.  Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community. The Vigil'Roc Study Group.

Authors:  F W Goldstein; Y Péan; J Gertner
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

7.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

Review 8.  Glycopeptides in the treatment of staphylococcal infections.

Authors:  F D Daschner; A Kropec
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995       Impact factor: 3.267

9.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

10.  The clinical and molecular epidemiology of bacteremias at a university hospital caused by pneumococci not susceptible to penicillin.

Authors:  F Moreno; C Crisp; J H Jorgensen; J E Patterson
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  4 in total

Review 1.  Use of antimicrobial drugs in veterinary practice.

Authors:  A M Johnston
Journal:  BMJ       Date:  1998-09-05

Review 2.  Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

3.  Factors determining the outcome of children hospitalized with severe pneumonia.

Authors:  Karalanglin Tiewsoh; Rakesh Lodha; Ravindra M Pandey; Shobha Broor; M Kalaivani; Sushil K Kabra
Journal:  BMC Pediatr       Date:  2009-02-23       Impact factor: 2.125

4.  Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?

Authors:  Ignatius T Yu; Zhan Hong Xie; Kelvin K Tsoi; Yuk Lan Chiu; Siu Wai Lok; Xiao Ping Tang; David S Hui; Nelson Lee; Yi Min Li; Zhi Tong Huang; Tao Liu; Tze Wai Wong; Nan Shan Zhong; Joseph J Sung
Journal:  Clin Infect Dis       Date:  2007-03-09       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.